Skip to main content

Table 3 Adverse events by adapted ICD10 main class, number of subjects (N) and event count (F) in all study subjects during the whole intervention period

From: Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood pressure

Classified Event

All

Krill Powder

Placebo

F

N

%

F

N

%

F

N

%

Totala

80

26

74.3

30

10

55.6

50

16

94.1

Gastrointestinal

23

13

37.1

11

5

27.8

12

8

47.1

Mental, behavioral

2

2

5.7

2

2

11.8

Musculosceletal (inc. injuries)

15

9

25.7

4

3

16.7

11

6

35.3

Nervous system (inc. headache)

14

7

20.0

8

3

16.7

6

4

23.5

Other (inc. unclassified abnormal lab values)

6

5

14.3

6

5

29.4

Respiratory (inc. common cold)

20

15

42.9

7

5

27.8

13

10

58.8

  1. aRate ratio (active/placebo) of adverse event counts (poisson regression model), contrast estimate results: mean (0.5667; Confidence limits 0.3604; 0.8911)